Heartflow Stock
Heartflow, Inc. Common Stock
Company data
- Sector
- Healthcare
- Industry
- Medical - Healthcare Information Services
- Country
- United States
- CEO
- John Farquhar
- Employees
- 843
- Market cap
- $4.2 B
- IPO
- 07/08/2025
HeartFlow, Inc. operates as a global medical technology firm in the Healthcare sector, specializing in providing non-surgical solutions for the diagnosis and ongoing management of coronary artery disease. Founded in 2007, the company is headquartered in San Francisco, USA. The innovative HeartFlow Platform employs…
Company description based on the data provider's company data, AI-assisted, created on 16/10/2026. Not investment advice.
Heartflow stock: price history
1D
-5.1%
1W
-2.9%
1M
-0.0%
6M
+54.1%
YTD
+65.7%
1Y
+44.3%
2Y
–
5Y
–
10Y
–
Next earnings date
Next earnings date
11/11/2026 (in 25 days)
Volatility around earnings
~83% stronger price swings than usual
Heartflow stock scores
- Valuation
Visible after free registration
- Trend
Visible after free registration
- Quality
Visible after free registration
- Dividend
Visible after free registration
- Growth
Visible after free registration
- Insider
Visible after free registration
- Earnings
Visible after free registration
- Revisions
Visible after free registration
- Sentiment
Visible after free registration
- Short Pressure
Visible after free registration
Register for free
Unlock all 11 scores
- 5 credits free on registration
- Access to virtual portfolios and watchlist
- No credit card, no payment details needed
- No subscription, no minimum term
- Our own servers in Germany, no US cloud
Deterministically calculated from financial metrics, not investment advice. Updated nightly, last on 17/10/2026.
Business model & megatrends
Robust business model that benefits noticeably from at least one megatrend.
1 more assignment (Enabler/Second row) Pro-only.
HeartFlow operates a medical technology platform that uses artificial intelligence and computational fluid dynamics to create three-dimensional digital cardiac models. These models are based on CT angiography scans and enable physicians to non-invasively analyze blood flow as well as stenoses and plaque composition to diagnose coronary artery disease more precisely and ensure its management.
- Revenue model
- Transactional
- Recurring revenue
- High
- Pricing power
- Moderate
- Moat
- None
- Moat type
- None
- Capital intensity
- Low
- Customer concentration
- Unknown
Ask the agents about Heartflow
Analyst assessment of Heartflow
PRICE TARGET LOW
US$37.00
CONSENSUS
US$46.14
MEDIAN
US$45.00
PRICE TARGET HIGH
US$56.00
0
STRONG BUY
5
BUY
1
HOLD
0
SELL
0
STRONG SELL
6
TOTAL · Buy
As of: 22/09/2026
Heartflow stock metrics
P/E
-34.01
P/B
14.92
EV/EBITDA
-39.56
RETURN ON EQUITY
-5.6%
NET MARGIN
-24.6%
DEBT/EQUITY
0.1
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
77.3%
FLOAT SHARES
67,203,850
AVG. DAILY VOLUME (30D)
1,866,939
Insider transactions (SEC)
Farquhar John C.M.
Rogers Campbell
Rogers Campbell
Rogers Campbell
Verghese Vikram
Attention
1 mention today in US forums, about the same as yesterdayPrice since yesterday: -5.1%
Forums (Reddit)
Institutional holders
Comparable stocks
Frequently asked questions about Heartflow stock
What does Heartflow do?
Heartflow, Inc. Common Stock is a company in the Healthcare sector, Medical - Healthcare Information Services industry, headquartered in United States.
The CEO is John Farquhar, the company employs around 843 people.
The IPO was on 07/08/2025; the stock trades on NASDAQ under the ticker HTFL.
What do analysts say about Heartflow stock?
6 analysts rate the stock, the consensus is Buy (as of 22/09/2026).
The average price target is US$46.14, ranging from US$37.00 to US$56.00, with a median of US$45.00.
This is an external assessment, not a statement by Market Jury.
When does Heartflow report next?
The next earnings date is 11/11/2026.
Around past earnings, price swings were roughly 83% stronger than usual.
Does Heartflow pay a dividend?
No, Heartflow currently does not pay a dividend.
Which stocks are comparable to Heartflow?
Comparable stocks include Hinge Health, HealthEquity, Omada Health, Teladoc Health, Evolent Health, SOPHiA GENETICS and Optima Health.
How can I get Heartflow stock analyzed?
Clicking "Analyze stock" lets five strategies assess Heartflow against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.